140 related articles for article (PubMed ID: 20216404)
41. MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway.
Du C; Yi X; Liu W; Han T; Liu Z; Ding Z; Zheng Z; Piao Y; Yuan J; Han Y; Xie M; Xie X
BMC Cancer; 2014 Nov; 14():869. PubMed ID: 25417825
[TBL] [Abstract][Full Text] [Related]
42. Immunohistochemistry of breast tumor markers on archived bouin-fixed paraffin-embedded tissues.
Gagnon JF; Sanschagrin F; Jacob S; Provencher L; Morin C; Diorio C
Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):168-72. PubMed ID: 20930615
[TBL] [Abstract][Full Text] [Related]
43. Automated Immunohistochemistry Assay for the Detection of Napsin-A in Formalin-Fixed Paraffin-Embedded Tissues from Lung Tumors.
Cintrón RV; Jusino JA; Conte-Miller M; Martínez AJ; Mendoza A
Methods Mol Biol; 2021; 2279():23-33. PubMed ID: 33683683
[TBL] [Abstract][Full Text] [Related]
44. Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer.
Rimawi MF; De Angelis C; Contreras A; Pareja F; Geyer FC; Burke KA; Herrera S; Wang T; Mayer IA; Forero A; Nanda R; Goetz MP; Chang JC; Krop IE; Wolff AC; Pavlick AC; Fuqua SAW; Gutierrez C; Hilsenbeck SG; Li MM; Weigelt B; Reis-Filho JS; Kent Osborne C; Schiff R
Breast Cancer Res Treat; 2018 Feb; 167(3):731-740. PubMed ID: 29110152
[TBL] [Abstract][Full Text] [Related]
45. Comparison of formalin-free tissue fixatives: a proteomic study testing their application for routine pathology and research.
Kothmaier H; Rohrer D; Stacher E; Quehenberger F; Becker KF; Popper HH
Arch Pathol Lab Med; 2011 Jun; 135(6):744-52. PubMed ID: 21631267
[TBL] [Abstract][Full Text] [Related]
46. Evaluation and validation of a pretreatment method for automated genomic DNA and RNA extraction from clinical formalin-fixed paraffin-embedded samples using the MagNA Pure Compact System.
Sawamura T; Kikuchi A; Wakayama Y; Sakuma H; Katoh T; Daimaru O; Nakakita T; Itoh S
Clin Lab; 2011; 57(9-10):807-10. PubMed ID: 22029202
[No Abstract] [Full Text] [Related]
47. Concurrent Immunohistochemical Localization and Western Blot Analysis of the MIF Receptor, CD74, in Formalin-Fixed, Paraffin-Embedded Tissue.
Graham A; Nothnick WB
Methods Mol Biol; 2020; 2080():123-134. PubMed ID: 31745876
[TBL] [Abstract][Full Text] [Related]
48. Integrated Analysis of PTEN and p4EBP1 Protein Expression as Predictors for pCR in HER2-Positive Breast Cancer.
Loibl S; Darb-Esfahani S; Huober J; Klimowicz A; Furlanetto J; Lederer B; Hartmann A; Eidtmann H; Pfitzner B; Fasching PA; Tiemann K; Jackisch C; Mehta K; von Minckwitz G; Untch M; Denkert C
Clin Cancer Res; 2016 Jun; 22(11):2675-83. PubMed ID: 26758558
[TBL] [Abstract][Full Text] [Related]
49. Precise Quantitation of PTEN by Immuno-MRM: A Tool To Resolve the Breast Cancer Biomarker Controversy.
Ibrahim S; Lan C; Chabot C; Mitsa G; Buchanan M; Aguilar-Mahecha A; Elchebly M; Poetz O; Spatz A; Basik M; Batist G; Zahedi RP; Borchers CH
Anal Chem; 2021 Aug; 93(31):10816-10824. PubMed ID: 34324311
[TBL] [Abstract][Full Text] [Related]
50. Automated immunohistochemical staining of formalin-fixed and paraffin-embedded tissues using a catalyzed signal amplification method.
Hashizume K; Hatanaka Y; Kamihara Y; Tani Y
Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):54-60. PubMed ID: 11277416
[TBL] [Abstract][Full Text] [Related]
51. Clinical Usefulness of a One-Tube Nested Reverse Transcription Quantitative Polymerase Chain Reaction Assay for Evaluating Human Epidermal Growth Factor Receptor 2 mRNA Overexpression in Formalin-Fixed and Paraffin-Embedded Breast Cancer Tissue Samples.
Wang HY; Ahn S; Park S; Kim S; Lee H
Pathobiology; 2017; 84(2):57-70. PubMed ID: 27544315
[TBL] [Abstract][Full Text] [Related]
52. Features of the reversible sensitivity-resistance transition in PI3K/PTEN/AKT signalling network after HER2 inhibition.
Goltsov A; Faratian D; Langdon SP; Mullen P; Harrison DJ; Bown J
Cell Signal; 2012 Feb; 24(2):493-504. PubMed ID: 21996585
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of PIK3CA mutation status, PTEN and androgen receptor expression for metastasis-free survival in HER2-positive breast cancer patients treated with trastuzumab in adjuvant setting.
Adamczyk A; Niemiec J; Janecka A; Harazin-Lechowska A; Ambicka A; Grela-Wojewoda A; Domagała-Haduch M; Cedrych I; Majchrzyk K; Kruczak A; Ryś J; Jakubowicz J
Pol J Pathol; 2015 Jun; 66(2):133-41. PubMed ID: 26247526
[TBL] [Abstract][Full Text] [Related]
54. Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma.
Capodanno A; Camerini A; Orlandini C; Baldini E; Resta ML; Bevilacqua G; Collecchi P
Hum Pathol; 2009 Oct; 40(10):1408-17. PubMed ID: 19428048
[TBL] [Abstract][Full Text] [Related]
55. Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.
Rebelatto MC; Midha A; Mistry A; Sabalos C; Schechter N; Li X; Jin X; Steele KE; Robbins PB; Blake-Haskins JA; Walker J
Diagn Pathol; 2016 Oct; 11(1):95. PubMed ID: 27717372
[TBL] [Abstract][Full Text] [Related]
56. Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue--a new option for predictive biomarker assessment in breast cancer.
Müller BM; Kronenwett R; Hennig G; Euting H; Weber K; Bohmann K; Weichert W; Altmann G; Roth C; Winzer KJ; Kristiansen G; Petry C; Dietel M; Denkert C
Diagn Mol Pathol; 2011 Mar; 20(1):1-10. PubMed ID: 21326033
[TBL] [Abstract][Full Text] [Related]
57. Optimal protocol for PTEN immunostaining; role of analytical and preanalytical variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues.
Maiques O; Santacana M; Valls J; Pallares J; Mirantes C; Gatius S; García Dios DA; Amant F; Pedersen HC; Dolcet X; Matias-Guiu X
Hum Pathol; 2014 Mar; 45(3):522-32. PubMed ID: 24457075
[TBL] [Abstract][Full Text] [Related]
58. Immunohistochemical detection of progesterone receptor in formalin-fixed and paraffin-embedded breast cancer tissue using a monoclonal antibody.
Scharl A; Vierbuchen M; Conradt B; Moll W; Würz H; Bolte A
Arch Gynecol Obstet; 1990; 247(2):63-71. PubMed ID: 2350195
[TBL] [Abstract][Full Text] [Related]
59. E- to N-cadherin switch in melanoma is associated with decreased expression of phosphatase and tensin homolog and cancer progression.
Lade-Keller J; Riber-Hansen R; Guldberg P; Schmidt H; Hamilton-Dutoit SJ; Steiniche T
Br J Dermatol; 2013 Sep; 169(3):618-28. PubMed ID: 23662813
[TBL] [Abstract][Full Text] [Related]
60. Estimation of tumor growth fractions in archival formalin-fixed, paraffin-embedded tissues using two anti-PCNA/Cyclin monoclonal antibodies. Factors affecting reactivity.
Gelb AB; Kamel OW; LeBrun DP; Warnke RA
Am J Pathol; 1992 Dec; 141(6):1453-8. PubMed ID: 1281622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
